What other stocks do shareholders of ePlus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ePlus investors own include Co-Diagnostics (CODX) , Actinium Pharmaceuticals (ATNM) , Curaleaf (CURLF) , Sierra Oncology (SRRA) , Tonix Pharmaceuticals (TNXP) , Aphria (APHA) , Digital Ally (DGLY) , iBio (IBIO) , T2 Biosystems (TTOO) .

How do I buy shares of ePlus?

Shares of PLUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

CNSX:PLUS

ePlus (PLUS) Stock Price, News & Analysis

→ AI “wealth window” is closing soon! (From Paradigm Press) (Ad)

Free PLUS Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 20,900 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get ePlus alerts:

Ad Paradigm Press

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

About ePlus

Plus Products Inc. develops, manufactures, and sells cannabis products in California. The company offers cannabis-infused edibles to the regulated medicinal and adult-use, or recreational markets. It sells products under the PLUS brand to dispensaries and delivery service customers. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.

Ad Paradigm Press

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

Click here to find out that this 8,788% cryptocurrency is.

PLUS Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive PLUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ePlus and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CNSX
Sector: Medical
Industry: Pharmaceuticals - Other
Sub-Industry: N/A
Current Symbol: CNSX:PLUS
CUSIP: N/A
CIK: 1022408
Web: www.plusproductsinc.com
Phone: +1 213.282.6987
Fax: N/A
Employees: 1,560
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Mr. Craig F. Heimark (Age 65)
Chairman, Chief Strategy Officer & Sec.
Comp: $386.29k
Mr. Jacob F. Heimark
Co-Founder, CEO & Director
Ms. Jennifer Tung
Special Advisor
Mr. Justin Gwin
Co-Founder & Head of R&D
Ms. Lucie Herold
Co-Founder & Head of Sales
Ms. Tessa O'Dowd
Chief Financial Officer
Dr. Ari Mackler
Chief Scientific Officer
Mr. Blake Brennan
Head of Investor Relations

Key Competitors

View All Competitors

PLUS Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of ePlus own?: Based on aggregate information from My MarketBeat watchlists, some companies that other ePlus investors own include Co-Diagnostics (CODX), Actinium Pharmaceuticals (ATNM), Curaleaf (CURLF), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Aphria (APHA), Digital Ally (DGLY), iBio (IBIO), T2 Biosystems (TTOO).
How do I buy shares of ePlus?: Shares of PLUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (CNSX:PLUS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

ePlus (PLUS) Stock Price, News & Analysis

About ePlus

PLUS Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

PLUS Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info